Dexmedetomidine’s effect on neonatal sedation, pain, respiratory status and cardiovascular system
摘要
Objective
To describe the effects of dexmedetomidine on sedation, pain, respiratory status, and hemodynamics in neonates.
MethodsA retrospective study of 206 infants in a level IV NICU (2016–2021) receiving continuous dexmedetomidine infusion. Pain/sedation scores, BP, vasopressor and inotrope score (VIS), and concomitant sedatives/analgesics (CSA) were recorded before and every 3–4 h for 24 h.
ResultsMedian PMA:32 weeks. Hypotension occurred in 26%, primarily in infants <32weeks PMA, correlating with higher VIS and CSA. CSA use significantly predicted vasopressors/inotrope use.
ConclusionDexmedetomidine, with CSA, increases cardiovascular instability in preterm infants who have unique myocardial structure and function and therefore higher vulnerability.
Clinical Trial Registration (if any)None (not applicable).